Who Paid My Doc
Phase II DRF study of NR2B modulation in MDD
Research payments
$5,185,137
Through program year 2025, $5,185,137 in research payments was reported against Phase II DRF study of NR2B modulation in MDD, across 48 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $4,640 | 8 |
| 2024 | Research | $5,180,497 | 40 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Benny Barnhart Wichita Falls, TX Named on 10 payments
- Alain Katic Bellaire, TX Named on 2 payments
- Jose Gamez Hialeah, FL Named on 2 payments
- Saundra Maass-Robinson Atlanta, GA Named on 2 payments
- Shishuka Malhotra Canton, OH Named on 2 payments
- Marc Shay Amesbury, MA Named on 2 payments
- Sherry Soefje Oceanside, CA Named on 2 payments
- Charles Montano Cromwell, CT Named on 2 payments
- Neeraj Gupta Long Beach, CA Named on 2 payments
- Daniel Chueh Orange, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.